En prognostisk transkriptomisk signatur for kronisk hypersensitivitetspneumonitis (PREDICT-HP)
Udvikling og validering af en prognostisk transkriptomisk signatur for kronisk hypersensitivitetspneumonitis
Up to 150 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.
Studieoversigt
Status
Status
Betingelser
Betingelser
Detaljeret beskrivelse
Hypersensitivity pneumonitis is an immunologically mediated form of lung disease, resulting from inhalation exposure to a large variety of antigens. For unknown reasons, a subgroup of patients with HP without a known inciting antigen exposure develops chronic disease with progressive pulmonary fibrosis (the leading cause of death). Accurately identifying patients at risk of disease progression is necessary for prognosis and therapy.
Enrolled subjects will be followed for 24 months and complete 5 visits to one of the study centers. Blood biomarkers will be collected in addition to other clinical data to determine if these biomarkers can predict disease progression.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Kontakter og lokationer
Studiesteder
-
-
Arizona
-
Tucson, Arizona, Forenede Stater, 85719
- University of Arizona
-
-
California
-
Sacramento, California, Forenede Stater, 95817
- University of California Davis
-
-
Colorado
-
Denver, Colorado, Forenede Stater, 80206
- National Jewish Health
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60637
- University of Chicago
-
-
Minnesota
-
Rochester, Minnesota, Forenede Stater, 55905
- Mayo Clinic
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75390
- University of Texas Southwestern
-
-
Utah
-
Salt Lake City, Utah, Forenede Stater, 84108
- University of Utah
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
The study population consists of men and women aged 18 to 85 years old with a diagnosis of chronic hypersensitivity pneumonitis.
Beskrivelse
Inclusion Criteria:
- Diagnosis of chronic hypersensitivity pneumonitis
- Age 18 through 85 years.
- Diagnosis of chronic hypersensitivity pneumonitis by HRCT
- Able to understand and sign a written informed consent form.
- Able to understand the importance of adherence to the study protocol and willing to follow all study requirements
Exclusion Criteria:
- Not a suitable candidate for enrollment or unlikely to comply with the requirements of this study
- Known explanation for the interstitial lung disease
- Clinical diagnosis of any connective tissue disease
- Listed or expected to receive a lung transplant within 4 months from enrollment
- Pregnant women
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: CASE_ONLY
- Tidsperspektiver: PROSPECTIVE
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Tid til absolut FVC (forventet procent) fald ≥10 procent
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Tid til absolut DLCO (forventet procent) fald ≥10 procent
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Tid til relativ FVC (forventet procent) fald ≥10 procent
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Tid til relativ DLCO (forventet procent) fald ≥10 procent
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Tid til relativ DLCO (forventet procent) fald ≥15 procent
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Tid til første dømt akut kronisk overfølsomhed pneumonitis eksacerbation
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Behov for en ny behandling med orale eller intravenøse steroider
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Tid til død af enhver årsag
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Ændring fra baseline i dyspnø ved brug af St. George's Respiratory Questionnaire aktivitetsscore ved måned 12
Tidsramme: 12 måneder
|
12 måneder
|
|
|
Skift fra baseline i 6-minutters gåafstand ved 6. måned
Tidsramme: 6 måneder
|
6 måneder
|
|
|
Skift fra baseline i 6-minutters gåafstand ved måned 12
Tidsramme: 12 måneder
|
12 måneder
|
|
|
Skift fra baseline i 6-minutters gåafstand ved måned 18
Tidsramme: 18 måneder
|
18 måneder
|
|
|
Skift fra baseline i 6-minutters gåafstand ved måned 24
Tidsramme: 24 måneder
|
24 måneder
|
|
|
Rate af fald i FVC (forventet procent) over 24 måneder
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Rate af fald i FVC (ml) over 24 måneder
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Fald i DLCO (forudsagt procent) over 24 måneder
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Rate af fald i DLCO (mmol/min/kpa) over 24 måneder
Tidsramme: Op til 24 måneder
|
Op til 24 måneder
|
|
|
Change from baseline in St. George's Respiratory Questionnaire total score at month 6
Tidsramme: 6 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
6 months
|
|
Change from baseline in St. George's Respiratory Questionnaire total score at month 12
Tidsramme: 12 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
12 months
|
|
Change from baseline in St. George's Respiratory Questionnaire total score at month 18
Tidsramme: 18 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
18 months
|
|
Change from baseline in St. George's Respiratory Questionnaire total score at month 24
Tidsramme: 24 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
24 months
|
|
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 6
Tidsramme: 6 months
|
Scores range from 0 to 120, with higher scores indicating greater breathlessness. |
6 months
|
|
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 12
Tidsramme: 12 months
|
Scores range from 0 to 120, with higher scores indicating greater breathlessness. |
12 months
|
|
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 18
Tidsramme: 18 months
|
Scores range from 0 to 120, with higher scores indicating greater breathlessness. |
18 months
|
|
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 24
Tidsramme: 24 months
|
Scores range from 0 to 120, with higher scores indicating greater breathlessness. |
24 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 6
Tidsramme: 6 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
6 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 12
Tidsramme: 12 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
12 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 18
Tidsramme: 18 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
18 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 24
Tidsramme: 24 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
24 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 6
Tidsramme: 6 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
6 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 18
Tidsramme: 18 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
18 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 24
Tidsramme: 24 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
24 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 6
Tidsramme: 6 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
6 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 12
Tidsramme: 12 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
12 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 18
Tidsramme: 18 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
18 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 24
Tidsramme: 24 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
24 months
|
|
Change from baseline in CT visual (≥10 percent) score at month 12
Tidsramme: 12 months
|
Visual scores range from 0 to 100, with higher scores indicating more lung fibrosis. |
12 months
|
|
Change from baseline in CT visual (≥10 percent) score at month 24
Tidsramme: 24 months
|
Visual scores range from 0 to 100, with higher scores indicating more lung fibrosis. |
24 months
|
|
Change from baseline in CT quantitative (≥3.4) score at month 12
Tidsramme: 12 months
|
CT quantitative scores range from 0 to no upper limits, with higher scores indicating more lung fibrosis. |
12 months
|
|
Change from baseline in CT quantitative (≥3.4) score at month 24
Tidsramme: 24 months
|
CT quantitative scores range from 0 to no upper limits, with higher scores indicating more lung fibrosis. |
24 months
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Evans Fernández, MD, MS, National Jewish Health
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- R01HL148437 (U.S. NIH-bevilling/kontrakt)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .